Application of PLGA in Tumor Immunotherapy

Area of Science:

• Biomedical Engineering
• Oncology
• Immunotherapy

Background:

• Biodegradable polymers like Polylactic-co-glycolic acid (PLGA) are crucial in biomedicine.
• PLGA is widely used in drug delivery, tissue engineering, and 3D printing.
• Tumor immunotherapy is a rapidly advancing field for cancer treatment.

Purpose of the Study:

• To review recent advances and challenges of PLGA in tumor immunotherapy.
• To explore PLGA's role as a carrier for antigens and its impact on immune response.
• To highlight PLGA's potential in developing novel cancer therapies.

Main Methods:

• Review of existing literature on PLGA applications in cancer immunotherapy.
• Analysis of PLGA's function in antigen delivery, vaccine formulation, and immune cell modulation.
• Discussion of PLGA's physical properties and surface modification potential.

Main Results:

• PLGA serves as an effective carrier for tumor antigens, enhancing immune attack.
• PLGA can be formulated into tumor vaccines and immunoadjuvants to boost immunotherapy efficacy.
• PLGA nanoparticles modulate immune cell activity and improve tumor antigen presentation.

Conclusions:

• PLGA demonstrates significant potential in advancing tumor immunotherapy.
• PLGA-based drug delivery systems offer versatile applications for personalized cancer treatment.
• Further research is needed to overcome challenges and optimize PLGA for oncology therapy.